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Abstract
Objective: Endovascular techniques are providing options to surgical/percutaneous cell transplantation methods. Some
cells, e.g. insulin producing cells, are not suitable for intra-luminal transplantation and for such cells, other options must be
found. We have constructed a ‘‘nanocatheter’’ with a penetrating tip for vessel perforation, thereby creating a working
channel for parenchymal access by endovascular technique. To finish the procedure safely, the distal tip is detached to
provide a securing plug in the vessel wall defect.
Materials and Methods: We have performed interventions with full clinical integration in the superior mesenteric artery
(SMA), the subclavian artery and the external carotid artery in rabbits. No hemorrhagic- or thromboembolic events occurred
during the procedure. Stenosis formation and distal embolisation were analyzed by angiography and macroscopic
inspection during autopsy at five, 30 and 80 days. All animals and implanted devices were also evaluated by micro-
dissections and histochemical analysis.
Results: In this study we show safety data on the trans-vessel wall technique by behavioral, angiographical and histological
analysis. No stenosis formation was observed at any of the follow-up time points. No animals or organs have shown any
signs of distress due to the intervention. Histological examination showed no signs of hemorrhage, excellent
biocompatibility with no inflammation and a very limited fibrous capsule formation around the device, comparable to
titanium implants. Further, no histological changes were detected in the endothelia of the vessels subject to intervention.
Conclusions: The trans-vessel wall technique can be applied for e.g. cell transplantations, local substance administration
and tissue sampling with low risk for complications during the procedure and low risk for hemorrhage, stenosis
development or adverse tissue reactions with an 80 days follow-up time. The benefit should be greatest in organs that are
difficult or risky to reach with surgical techniques, such as the pancreas, the CNS and the heart.
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Introduction
Cell based therapies are in clinical trials in e.g. Parkinsons
disease [1,2], ischemic stroke [3,4] and spinal cord lesions [5].
Outside the CNS, other clinical trials involving i.e. muscle
dystrophy [6,7], ischemic heart disease [8], graft versus host
disease [9,10] and type I diabetes mellitus [11,12] have yielded
promising results.
Endovascular based specific intra-arterial approaches have
previously been shown to achieve superior engraftment levels
vis-a `-vis intravenous methods [13,14]. However, not all cells are
even possible to engraft by intraluminal methods as illustrated by a
specific intra-arterial approach to insulin producing cell trans-
plantation to the pancreas [15]. For cell transplantation schemes
aimed at organs that are difficult or hard to reach, such as the
pancreas, the CNS, the heart and the lung, endovascular methods
can provide a minimally invasive option. An example of such
transplantations is the percutaneous approach to transplantation
of insulin-producing cells via the portal vein. It has been
speculated that it is dependent on transplanted cell acting as
embolic material in the low pressure system that the portal vein
constitutes [16]. Nevertheless, the portal vein approach to
transplantation is today the most promising one due to the risks
of existing open surgical options [17,18]. Transplantation of
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favorable conditions such as the higher oxygen tension in the
pancreatic tissue compared to the liver. Further, superior
endocrine glucose regulation capacity can be reached with cells
situated in the pancreas compared to the liver. It would therefore
be beneficial with an accurate, minimal invasive, method of
transplantation to the pancreas parenchyma [19].
The Extroducer is designed for exiting the micro- or macro-
vasculature throughout the body on both the arterial and the
venous side (fig. 1) [20]. The design and concept of the device is
associated with Seldingers original work describing the introducer
[21]. A standard endovascular clinical catheter system, including
an introducer, a guidecatheter and a microcatheter, is navigated
within the vasculature to any target organ. Once the microcatheter
is in the desired location within the microvasculature, the
Extroducer system is advanced through the microcatheter. The
Extroducer then safely penetrates the arterial or venous wall, as a
‘‘nanocatheter’’, to reach the extravascular space, e.g. the
parenchyma of any desired organ. The system thereby creates a
working channel in order to be able to administrate or sample cells
and substances to/from the extra-vasal space, and to make closure
of the vessel wall safe even on the arterial side. To ensure the
closure of the vessel wall, the most distal part of the Extroducer is
detached and left behind. The rationale behind this technique is to
combine minimal invasiveness of an endo-luminal approach with
an accurate administration in a desired anatomical location.
The Extroducer is manufactured in nitinol; a nickel/titanium
alloy with both memory and super elastic properties [22]. These
special properties are the foundation to the use of nitinol in stent
fabrication in clinical practice. Thus the excellent biocompatibility
of nitinol [23] has been extensively studied, especially with respect
to direct vascular inner wall interactions, i.e. endothelium [24] but
no in vivo studies have been performed with nitinol penetrating the
vascular wall. However, nitinol corrosive bi-products can have a
negative effect on smooth muscle cells in vitro [25]. It should be
noted that to achieve a cytotoxic effect, a continuous current was
used over a nitinol wire for 24 hours thereby dissolving it into
Titanium and Nickel ions.
Study Design
The aim of this study was to evaluate long term effects of the
trans-vessel wall technique where the distal portions of the
Extroducer prototypes are detached in rabbits. Two primary
endpoints were considered; stenosis at the site of intervention,
ischemic complications distal to the intervention and late
hemorrhagic complications. Further, a model of repeated
endovascular intervention in the rabbit was established.
Since this is the first follow up study of the endovascular trans-
vessel wall intervention the study was organized as a continuous
enrollment of animals with successful interventions. A limitation
was set to maximum two hours femoral introducer time to avoid
ischemic damage in the hind limb of the rabbit. This time was
chosen in accordance with previous experiences from endovascu-
lar treatment of children with similar size of artery and introducer
sizes.
The interventions started with angiography to decide the most
suitable places for interventions and then as many interventions as
possible were performed in each subject within the time frame of
two hours of femoral introducer time. New subjects where
continuously enrolled to reach a total of 25 interventions for the
study. The acute phase of intervention was studied in a previous
article [20] and in the present study, we wanted to analyze the
potential complications during the subacute and chronic phase.
The follow up times where extended continuously from first five
days, then 30 days and finally 80 days when follow ups and
autopsies where performed without complications according to the
primary endpoints.
We designed the study to assess complications following the
trans-vessel wall technique in the vessel used for intervention and
also distal to the intervention. Complications were assessed by
follow-up angiography and histological examination as well as
observation of the clinical status of the animal. Complications were
considered to be hemorrhage at the interventional site at any time,
stenosis at the interventional site, thrombosis at the interventional
site and distal embolization. The secondary endpoint was efficacy
of creating the working channel from within the vascular tree to
the parenchyma of different organs.
Results
In this study we show that it is possible to, by endovascular
methods, reach several different parts of the body by perforating
the vessel wall from the inside to out, thereby creating a working
channel to the organ parenchyma without hemorrhagic compli-
cations during the acute- or chronic phase. The Extroducer and
the trans-vessel wall technique are fully integrated with clinical
standard material such as catheter systems and angiographical
equipment. We show that neither stenosis formation, distal
embolus formation, nor other adverse events occur with up to
three months follow-up. The Extroducer interventions were
performed in the superior mesenteric artery (SMA) (n=9), the
subclavian artery (SCA) (n=14) and the external carotid artery
tree (ECA) (n=2).
We started with a total number of 25 primary trans-vessel wall
interventions in 17 animals. Working channels were established in
100% of the cases without acute hemorrhagic or thrombo-embolic
events, verified by DSA. Six of the interventions were aborted due
to distal tip detachment failure with our hand-made relatively
primitive electrolysis detachment method (leading to euthanasia of
3 animals and 3 that we were able to salvage to stay in the study).
Two animals were euthanized by order of the veterinarian during
the follow-up period, one because of a non-related pulmonary
infection (but included and analyzed by histology) and the other
since it fulfilled the behavioral abortion point criteria after
24 hours (excluded from the study). That animal was then
autopsied and was found to have an embolic occlusion of the
Figure 1. Principal design of the tip of the Extroducer. A
principal drawing of the design of the distal tip is depicted with an
intrusion depth limiting collar. Proximal to the intrusion depth limiting
collar a electrolysis detachment zone is located. This image is previously
published under the Creative Commons Attribution License in
Lundberg et al, New endovascular method for transvascular exit of
arteries and veins: developed in simulator, in rat and in rabbit with full
clinical integration. PLoS One 5:e10449, 2010.
doi:10.1371/journal.pone.0023328.g001
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placement, but rather associated with the vascular navigation. The
final distribution of followed up animals were as follows; two at the
five days end point with only histological analysis of one, five at the
30 days end point and six at the 80 days end point with histological
analysis of one (with pulmonary infection) resulting in a total
number of 19 detached Extroducer tips (table 1).
Behavioral monitoring of all animals were performed for signs
of distress; especially from the prototypes placed in the SMA.
Behavioural observations were performed five times per week and
we observed no signs of distress in the animals followed during the
observation period. We postulated that a possible thrombo-
embolic complication in the SMA would have led to ischemia in
the bowel which in turn would have given clear signs of distress for
the animal and death. At the designated end time-points, cut down
technique was used to place the introducer in the same femoral
artery that had been used during the intervention. All follow-up
introducer placements were successful. The follow-up DSAs were
performed with at least two projection planes (fig. 2) and by 3D
angiography. Philips proprietary software for the Allura XD20 was
used to assess possible stenosis formation. We did not detect any
stenosis or distal embolus at any follow-up time points. Further, we
also performed navigations with microguide wires and micro-
catheters without complications distal to the detached distal tips.
In the follow up DSA, we also found that 4 of 19 (21%) of the
detached tips were no longer placed through the vessel wall but
had instead been ‘‘pushed’’ outward through the endothelium to
the extra-vascular space immediately adjacent to the vessel
penetration site. For prototype tips exhibiting this dislodgement
through the endothelium, no vascular alterations or stenoses was
observed.
Another interesting finding was that for the five prototypes
detached precisely in the rotator plane of the humero-scapular
joints in the SCA, tips were dislodged into the lumen of the vessel
with the depth limiting collar pointed distally in the flow of blood.
For all other tips, detached millimeters proximal or distal to the
rotational plane through the SCA, this phenomena was not seen.
After the euthanasia procedures, we performed careful
dissections to analyze macroscopic changes in the bowel, forelimb
or facial muscles. All tissues examined where normal without signs
of thrombo-embolic complications. To further analyze the effect of
the detached prototypes, tissue samples were obtained en bloc with
vessels and surrounding tissue.
We performed histological analysis with the prototypes in situ by
grind-cutting technique and then consulted an external, indepen-
dent, evaluator with expertise in the field of titanium implants.
The evaluation showed full biocompatibility with a very small
fibrotic capsule (,1 mm) formed around the detached distal tips.
No ongoing inflammation was observed around any of the
detached tips. Around one (of the total number 14 left in place)
implant three macrophages were indentified in the area of the
detached distal tip. This was observed in a day five animal. The
endothelia showed no signs of alterations adjacent to the detached
tips. In conclusion, the biocompatibility of the trans-vessel wall
detached nitinol tips were all comparable to titanium implants
(fig. 3).
Prototypes excluded due to failed detachment were analyzed by
scanning electron microscopy (SEM) since monitoring of electric
current gave limited prognostic information about failure to
detach (fig. 4). In failed detachments, large amounts of chloride
were observed by energy dispersive spectroscopy (EDS) of the
surface (6–10 wt%) indicating formation of titanium chloride ions
in a passive sheet, thus providing current transmission without
electrolysis.
Discussion
To realize the full potential of the trans-vessel wall technique,
safety studies in several animals are an absolute necessity. In this
study we show, for survival times up to 80 days in rabbit, that
hemorrhage, stenosis formation or distal embolisation do not
occur with this technique. Moreover, the biocompatibility of the
trans-vessel wall implanted nitinol tips is excellent with no
inflammatory activation in the surrounding tissues.
In previous studies, we show that, for cells capable of
performing diapedesis, intra-arterial transplantation carries signif-
icant advantages with respect to engraftment compared to
intravenous methods [13]. However, the selective intra-arterial
method also has limitations in more specialized pathological
conditions and/or specialized cell systems; e.g. insulin producing
cells. Pre-clinical trials of specific intra-arterial transplantations
with insulin producing cells have hitherto only showed negative
results [15] and since open surgical options of accessing the
pancreas parenchyma itself carries unacceptable risks [17] the
portal vein approach has been developed [12]. In this study, the
SMA-placed device could be considered a simulation of a retro-
peritoneal intervention to reach the pancreas, thus this study
provides safety data and rationale for a continuing development of
the trans-vessel wall technique. Interventions aimed for the
pancreas are not possible in rabbits and therefore such studies
will be performed in swine. It should be noted that the usage of C-
arm based computerized tomography reconstructions with for
example Dyna-CT or XperCT technique in combination with 3D
roadmapping would add substantial information about the
relation of vessels and parenchyma, thereby facilitating directed
parenchymal access with the trans-vessel wall technique. Another
interesting new method is image fusion by previously acquired
magnetic resonance imaging volumes with 3D roadmaps. All these
new imaging techniques are transforming the field of endovascular
intervention where the trans-vessel wall technique could poten-
tially add a further tool in the toolbox of the interventional
radiologists.
Since nitinol is in clinical use in a wide variety of applications
with direct endothelial contact and in other types of implants, the
bio-compatibility is well studied [22,24]. Probably the best data set
of compatibility comes from stents developed in nitinol which
share at least the endothelial contact with the devices used in the
present study. The present study is, however, to our knowledge the
first study to describe the biocompatibility of nitinol when placed
through the vessel wall layers and reaching the extravascular
space. Our histological analysis shows minimal tissue reactions
without signs of inflammation in the extra-cellular matrix or in the
vessel walls. The design of the Extroducer prototypes evaluated in
this study makes it possible to manufacture future devices also in
bio-degradable material.
Table 1. Distribution of analysed detached tips.
SMA SCA ECA No of animals examined at timepoint
5 days 1 2 0 2
30 days 4 3 0 5
80 days 3 5 2 6
The distal tip placement distribution in animals not excluded, plotted against
time-points for follow-up. SMA=Superior Mesenteric Artery, SCA=Subclavian
artery, ECA=External Carotid Artery.
doi:10.1371/journal.pone.0023328.t001
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precisely in the rotator plane of the humero-scapular joints in the
SCA, were dislodged into the lumen of the vessel. This
phenomenon occurred due to the fact that the anterior extremities
of the rabbit were flexed in a certain position to facilitate body
fixation during the procedure and that the five Extroducer tips
were detached exactly in the plane of movement of the joint.
Subsequent analysis showed that the dislodgement of the
penetrating tip occurred immediately after the procedure when
the flexed anterior extremity regained its normal position. For the
other prototypes detached within other segments of the SCA
(millimeter more proximal or distal to the humero-scapular rotator
plane) and in all other vascular segments tested in the body, this
phenomenon was not observed. Thus, we do not consider it a
problem since the target organs primarily are pancreas, CNS,
heart and lung whereas the axillary cavity easily can be reached by
percutaneous methods.
When analyzing the failed detachment tips by SEM we showed
that a Titanium Chloride passive sheet was probably formed.
Titanium chloride molecules can provide a surface area that lets
electron pass through but without formation of soluble titanium or
nickel ions. This problem probably occurred due to the relatively
simple ‘‘home made’’ technique used for creating the insulation
defect required for electrolysis detachment. There are, however,
numerous commercially available solutions for detachment that
can easily be integrated with the trans-vessel wall technique in
industrialized manufacturing processes.
In conclusion this study shows that in large animals, the trans-
vessel wall technique has a 100% success rate in creating an
endovascular working channel to the parenchyma of any organ.
Further, no stenosis, hemorrhage, embolus release or adverse
tissue reactions are induced up to three months after the
interventions. The benefit of the trans-vessel wall technique
should be greatest in transplantations involving cells with limited
Figure 2. Follow Up of the Detached Distal Tips. In a. the initial follow up angiogram directly following detachment in the Superior Mesenteric
Artery (SMA) is shown with a square marking the blow-up in b. Arrows indicate the detached distal tip. In c. an SMA angiogram, performed 80 days
after the intervention in the same animal, is shown with a square indicating the blow-up in d. Arrows indicate the detached distal tip. In e. a
microphotograph of a histological van Geeson and toulene blue staining prepared by grind-cutting with a detached tip in situ, is shown. Scale
bar=100 mm. The blow-up in f shows the parylene coating surrounding the detached tip which is marked by an arrow. Note that no fibrous response
or inflammation is observable. Scale bar=4 mm.
doi:10.1371/journal.pone.0023328.g002
Figure 3. Histological Examination. After follow-up angiography, histological examinations were performed. In a. a microphotograph of a
representative grind-cut section from the SMA stained with van Geeson and toulene blue, is shown (scale bar=250 mm). In b. a high power field
microphotograph of van Geeson and toulene blue with phase contrast stained endothelium adjacent to a deposit tip, is shown. No cellular alterations
of the composition of the blood vessel is detected (scale bar=30 mm). In c. a microphotograph of van Geeson stained lymph node from the
mesentery adjacent to a detached tip, is shown. No signs of lymph node activation is seen (scale bar=30 mm).
doi:10.1371/journal.pone.0023328.g003
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ing insulin-producing cells in diabetes mellitus. The system can
potentially also be used for local substance administration or tissue
sampling, or for other diagnostic or therapeutic purposes in i.e. the
CNS, pancreas, heart and lung.
Materials and Methods
Ethic statement
All animal studies were conducted according to Karolinska
Institutet guidelines of animal experiments on small rodents and
rabbits. The studies were approved by the Northern regional
ethics committee for animal research in Stockholm, Sweden with
reference number N08/09.
Endovascular procedure
A total number of 17 New Zealand White rabbits were included
in this study, divided into three time-points; 5 days, 30 days and 80
days. Surgical anesthesia was induced by subcutaneous injection of
0.5 ml/kg Hypnorm (fentanyl citrate 0.315 mg/ml, fluanisone
10 mg/ml, Janssen Pharmaceutical, Belgium) combined with
5 mg diazepam. An intravenous line was established followed by
a bolus dose of Propofol and thereafter, the rabbit was intubated
with a size 3 pediatric tube and connected to a Siemens 900 servo
ventilator (Siemens Healthcare, London, United Kingdom).
Continuous infusion of propofol and fentanyl was used to sustain
surgical anesthesia.
All large animal angiography and endovascular intervention
was performed with a Philips XD20 angiographical equipment
(Philips medical system, the Netherlands). Visipaque 270 contrast
agent (GE healthcare, USA), was used in all angiography
applications.
The femoral artery was exposed surgically and a 4 French
introducer was inserted in the artery (Terumo, USA). Under
fluoroscopic and angiographic control, a 4 French Vertebral
guiding catheter (Cordis Corporation, USA) was navigated to
different parts of the vasculature of the rabbit. A Renegade micro-
catheter (Boston Scientific, USA) was inserted within the guiding
catheter and, together with a Transend Platinum Tip guidewire
(Boston Scientific, USA), navigated under angiographic control to
SMA, SCA and ECA branches. After having reached the desired
target location, the guidewire was withdrawn from the micro-
catheter and the Extroducer, within a PTFE-190 Sub-Lite wall
tubing (Agnthos AB, Stockholm, Sweden), was inserted and
deployed through the arterial wall and detached with electrolysis.
Maximal femoral artery introducer time was two hours. After
the interventions, gentle pressure was applied on the femoral
artery for 15 minutes, followed by Coseal
TM application and
another 15 minutes of pressure. The surgical incision was then
sutured and propofol infusion was discontinued. On reestablish-
ment of the coughing reflex, extubation was performed and the
animals were allowed to recover in their home cages. Behavioral
monitoring was performed five times per week.
When performing follow-up angiography, an introducer was
placed in the femoral artery under general anesthesia (see above)
and a diagnostic angiography was performed using a 4 French
diagnostic catheter. Thereafter the animal was sacrificed by a
lethal dose of Penthotal and the vasculature and organs, where
interventions had been performed, were dissected under surgical
microscope and samples for histological analysis were taken.
Histological examination
We performed histochemical analysis of blocks of tissue
containing the detached tips. The appropriate tissue was dissected
with fluoroscopic guidance. The tissue blocks were then mounted
in plastic and cut by specialized ground cutting technique
providing the possibility of leaving the metal tip in situ. Staining
was performed with van Geeson and toulene blue on grind cut
blocks and then visualized by light-microscopy.
An external, independent, evaluator from the department of
pathology, Karolinska University Hospital, Sweden, with expertise
on biological implants, was consulted for assessment of the
histological results. Samples were blinded with respect to time
and location for the evaluator and the benchmark for biocompat-
ibility were set as the tissue reaction produced by titanium
implants and counting of macrophages around the implant.
Scanning Electron Microscopy
For SEM investigations a Hitachi S-3700N was used (Hitachi
AB, Sweden). The SEM was connected to a Bruker AXS XFlash
Detector 4010 for spectroscopical analysis (Bruker Corp. US).
Samples were cleaned prior to analysis by rinsing with tap water.
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